Delta4 | AI Drug Discovery & Indication Expansion

Faster, Smarter Drug Discovery & Indication Expansion with AI

At Delta4, we combine systems biology, computational modeling, AI, and large-scale data to understand disease mechanisms, discover new therapeutic targets, and predict drug behavior in silico — accelerating every stage of drug development with precision and speed.

Who We Are

Crafting the treatments of the future.

Delta4 is a TechBio company focused on helping clients expand indications for existing drugs with known safety profiles.

We accelerate new treatment options to improve the health of patients and get them into their hands faster, more safely, and more efficiently than traditional approaches.

Building Global Networks to Advance Precision Medicine

We’re proud to share that Delta4 has been featured by the Austrian Research Promotion Agency (FFG) for our work advancing computational biology. At Delta4, we connect expertise, foster young talent, and leverage data-driven innovation to improve patient outcomes.

What We Do

AI-Powered Platform to Discover & Develop Therapies.

Cut Costs, Save Time, and Increase Success.

We help our clients discover undetected relationships between drugs with a known safety profile to identify new indications.

We do this by leveraging Hyper-C, our proprietary artificial intelligence powered platform that allows us to detect these relationships with unprecedented speed, accuracy, and efficiency.

Hyper-C is operated by our team of highly skilled computational biologists who carefully analyze the data to produce unique insights and detect drug indication expansion opportunities.

The results are new therapeutic options that find their way to market faster, more cost-effectively than ever before.

Get Involved

Work With Us

Interested in our Services?

Apply our in-silico models to accelerate your drug or indication program.

Our Technology

Explore how systems biology and AI power our predictive platform.

Interested in Partnering?

Collaborate with us on research, co-development, or consortia projects.

Our Partners & Clients

It’s an honor and a privilege to be working with the best of the best!

Top Pharma Germany

Top Pharma Scandinavia

Proud Member of Scientist.com

Streamlining Transparency and Cooperation

Scientist.com provides a unique platform where researchers and suppliers can both find each other and work together more easily. They provide a collaboration framework to streamline the typically long and tedious process of defining the terms and conditions of an agreement.

Members can work together smoothly and effortlessly by agreeing to the rules of the platform. The result is that together we can achieve the results we need faster.

“Delta4’s AI-Powered Hyper-C Platform Uncovers New Drug Indications, Expanding Treatment Potential for Iguratimod” – As Featured on Scientist.com

Are you a member of Scientist.com? View Our Profile

Latest News & Events

Stay up to date with all our activities

From the latest news and press releases to blog posts and important industry events, check here to stay current with what we’re up to and what we’re watching.

Three men sit at a table having a discussion; one has a laptop open, and documents and pens are on the table.

Delta4’s Year in Review: Strong Momentum in 2025 Fuels Ambitious Plans for 2026

January 9, 2026

As 2025 draws to a close, Delta4 reflects on a remarkable year of scientific achievement, strategic partnerships, and technological advancement. From securing national recognition to ...

$Person wearing blue gloves and a lab coat typing on a laptop in a laboratory setting.$

Long COVID: Symptoms, Causes, and How AI Is Ushering New Hope

December 15, 2025

Long COVID is a chronic state that can be diagnosed when symptoms or diagnosable conditions persist for at least three months following a SARS-CoV-2 infection. ...

Three people look at a computer screen displaying code, graphs, and data visualizations related to personalized medicine in an office setting.

Advancing Kidney Health Through Collaboration: Delta4’s Role in the PICKED Project

October 14, 2025

Chronic kidney disease (CKD) affects more than 850 million people worldwide, yet it remains one of the most underrecognized and underdiagnosed global health burdens. Despite ...